Table 6.
Parameter | Model input§ (95 % CI) | Source | |||
---|---|---|---|---|---|
a. Intervention effects and costs | |||||
Angiotensin converting enzyme inhibitor | |||||
RR1 | MI2 | 0.81(0.70 - 0.94) | [58] | ||
Stroke | 0.65(0.52 - 0.82) | ||||
Cost3 | 14.10 | [59] | |||
Angiotensin receptor blocker | |||||
RR | MI | 0.94 (0.85 - 1.03) | [60] | ||
Stroke | 0.91(0.85 - 0.98) | ||||
Cost | 64.83 | [59] | |||
Beta-blocker | |||||
RR | MI | 0.90 (0.78 - 1.03) | [58] | ||
Stroke | 0.83 (0.72 - 0.97) | ||||
Cost | 6.82 | [59] | |||
Biguanide | |||||
RR | MI | 0.67 (0.51 - 0.89) | [61] | ||
Stroke | 0.80 (0.50 - 1.27) | ||||
Cost | 21.15 | [59] | |||
Calcium channel blocker | |||||
RR | MI | 0.85 (0.78 - 0.92) | [62] | ||
Stroke | 0.66 (0.58 - 0.75) | ||||
Cost | 13.19 | [59] | |||
Soluble Aspirin | |||||
RR | MI | 0.77 (0.69 - 0.86) | [63] | ||
Stroke | 0.95 (0.85 - 1.06) | ||||
Cost | 14.79 | [59] | |||
Statin | |||||
RR | MI | 0.86 (0.82 - 0.90) | [64] | ||
Stroke | 0.90 (0.85 - 0.95) | ||||
Cost | 15.92 | [59] | |||
Sulfonylureas | |||||
RR | MI | 0.85 (0.74 - 0.97) | [61] | ||
Stroke | 0.91 (0.73 - 1.13) | ||||
Cost | 6.37 | [59] | |||
Thiazide diuretics | |||||
RR | MI | 0.84 (0.75 - 0.95) | [58] | ||
Stroke | 0.63 (0.57 - 0.71) | ||||
Cost | 1.18 | [59] | |||
b. Costs | |||||
Cost of CVD4 prevention | |||||
Patient cost per OPD5 visit | 15.1 | [34]¶ | |||
Provider cost per OPD visit | 7.15 | ||||
Provider cost per lab test | 4.07 | ||||
Cost of CVD treatment | |||||
Patient cost per CVD treatment | 194 | [35] | |||
MI | Mild stroke | Mod.6 stroke | Sev.7 stroke | ||
CVD risk - first year | 310 | 271 | 512 | 570 | Estimation |
CVD risk - subsequent years | 260 | 67 | 76 | 313 | |
CVD risk with diabetes - first year | 358 | 319 | 560 | 594 | |
CVD risk with diabetes - subsequent years | 308 | 115 | 124 | 361 | |
c. Disability weights8 | |||||
Acute MI | 0.42 (0.28 - 0.57) | [26] | |||
Mild stroke | 0.02 (0.01 - 0.04) | ||||
Moderate stroke | 0.08 (0.05 - 0.11) | ||||
Severe stroke | 0.54 (0.36 - 0.71) | ||||
d. Other probabilities | |||||
In the event of a first ever stroke, | |||||
what is the probability of a: | |||||
mild stroke for a CVD risk | 0.19 | [65, 66] | |||
moderate for a CVD risk | 0.44 | Extrapolation | |||
severe for a CVD risk | 0.27 | and | |||
mild stroke for a CVD risk with diabetes | 0.15 | assumptions | |||
moderate for a CVD risk with diabetes | 0.35 | ||||
severe for a CVD risk with diabetes | 0.50 | ||||
In the event of a subsequent stroke, | |||||
what is the probability of: | |||||
…mild stroke | 0.15 | ||||
…moderate stroke | 0.25 | ||||
…severe stroke | 0.60 |
1RR - Relative risk with beta distribution fitted; 2MI - Myocardial in arction; 3Cost - All costs are in 2012 US$ and were fitted with a gamma distribution; 4CVD - Cardiovascular disease; 5OPD - Out-patient department; 6Mod. - Moderate; 7Sev. - Severe; 8Beta distribution was fitted disability weights and other probabilities; §All model parameters were varied at ± 15 % unless stated; ¶ provider cost per OPD visit is the average cost per visit for the four facilities costed, provider cost per lab test available from Table 5, Patient cost per OPD visit was derived from annual patient cost divided by average number of clinic visits [34].